{"product_id":"johns-hopkins-wilmer-eye-institutes-35th-annual-current-concepts-in-ophthalmology-2022","title":"Johns Hopkins Wilmer Eye Institute’s 35th Annual Current Concepts in Ophthalmology 2022","description":"\u003ch3\u003eJohns Hopkins Wilmer Eye Institute’s 35th Annual Current Concepts in Ophthalmology 2022\u003c\/h3\u003e\n\u003cstrong\u003e Include: 14 videos + 53 pdfs, size: 15.93 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: ophthalmologists, optometrists, and ophthalmic allied health professionals\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Thursday, December 1, 2022, 8:00 AM – Friday, December 2, 2022, 6:00 PM, Johns Hopkins School of Medicine, Turner Auditorium, Baltimore , MD\u003cbr\u003eTarget Audience \u003cem\u003eSpecialties\u003c\/em\u003e – Ophthalmology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\u003cbr\u003eThis Current Concepts course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWHO SHOULD ATTEND\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis activity is intended for ophthalmologists, optometrists, and ophthalmic allied health professionals.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eSummarize the latest developments for the management of anterior and posterior segment problems.\u003c\/li\u003e\n\u003cli\u003eEvaluate emerging literature on the efficacy, safety, and cost-effectiveness of femtosecond-assisted laser cataract surgery.\u003c\/li\u003e\n\u003cli\u003eDiscuss new medical techniques, therapies and recently published, relevant clinical trials.\u003c\/li\u003e\n\u003cli\u003eFormulate current and advanced medical and surgical treatment strategies as well as imaging with corresponding ocular conditions, including: glaucoma, retina, anterior segment including “dry eye”, uveitis, refractive surgery and laser assisted cataract and corneal transplant surgery.\u003c\/li\u003e\n\u003cli\u003eExamine external legislative and internal practice issues impacting the field of ophthalmology.\u003c\/li\u003e\n\u003cli\u003eAssess the perioperative use of antibiotic and anti-inflammatory agents in patients undergoing eye surgery.\u003c\/li\u003e\n\u003cli\u003eIntegrate prescribed medical and surgical treatment options into everyday practice.\u003c\/li\u003e\n\u003c\/ol\u003e\u003cbr\u003eThe Johns Hopkins Wilmer Eye Institute’s 35th Annual \u003cem\u003eCurrent Concepts in Ophthalmology\u003c\/em\u003e (2022) was best for ophthalmologists, optometrists, residents, fellows, and allied eye care professionals who wanted a comprehensive, evidence-based update on the diagnosis and management of common eye diseases.\u003cbr\u003e\u003ch3\u003e👩‍⚕️ Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eOphthalmologists seeking updates on medical and surgical therapies across subspecialties\u003c\/li\u003e\n\u003cli\u003eOptometrists and general eye care providers who manage patients with routine and complex ocular conditions\u003c\/li\u003e\n\u003cli\u003eResidents and fellows in ophthalmology preparing for board exams or expanding their clinical knowledge\u003c\/li\u003e\n\u003cli\u003eAllied health professionals (nurses, technicians) supporting ophthalmic care in clinical practice\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e📚 What You’d Learn\u003c\/h3\u003e\u003cbr\u003eThe 2022 program highlighted recent developments in diagnosis, medical therapy, and surgical management of common eye diseases. Key topics included:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdvances in cataract and refractive surgery\u003c\/li\u003e\n\u003cli\u003eUpdates on glaucoma management and surgical innovations\u003c\/li\u003e\n\u003cli\u003eRetina and macular disease therapies, including anti-VEGF and imaging advances\u003c\/li\u003e\n\u003cli\u003eCorneal and external disease treatments\u003c\/li\u003e\n\u003cli\u003eOculoplastics and neuro-ophthalmology updates\u003c\/li\u003e\n\u003cli\u003eCase-based discussions bridging clinical trial findings with real-world practice\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eThursday, December 1, 2022\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome and Conference Goals\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:05AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eZoom Webinar Link\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:05AMPlease click on the PDF icon to view the syllabus email with Zoom Webinar link included. \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePerspectives on Forty Years in Ophthalmology\u003c\/strong\u003e\u003cbr\u003e8:05AM – 8:15AM\u003cbr\u003ePeter McDonnell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBeyond Descemet Membrane Endothelial Keratoplasty (DMEK)\u003c\/strong\u003e\u003cbr\u003e8:15AM – 8:25AM\u003cbr\u003eAlbert Jun, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Anterior Segment\u003c\/strong\u003e\u003cbr\u003e8:15AM – 10:15AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCorneal Infections: An Evidence-Based Update\u003c\/strong\u003e\u003cbr\u003e8:25AM – 8:35AM\u003cbr\u003eNakul Shekhawat, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePre-loaded Descemet Membrane Endothelial Keratoplasty (DMEK)\u003c\/strong\u003e\u003cbr\u003e8:35AM – 8:45AM\u003cbr\u003eMeraf A Wolle, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Complex Cataract Surgery in the Setting of Zonular Weakness\u003c\/strong\u003e\u003cbr\u003e8:45AM – 8:55AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e8:55AM – 9:05AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Management of Keratoconus\u003c\/strong\u003e\u003cbr\u003e9:05AM – 9:15AM\u003cbr\u003eUri Soiberman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNew Frontiers in Dry Eye Procedures\u003c\/strong\u003e\u003cbr\u003e9:15AM – 9:25AM\u003cbr\u003eLee W Guo, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e9:35AM – 9:45AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery in Eyes with Keratoconus\u003c\/strong\u003e\u003cbr\u003e10:15AM – 10:25AM\u003cbr\u003eDivya Srikumaran, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Anterior Segment\u003c\/strong\u003e\u003cbr\u003e10:15AM – 11:30AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCorneal Complications following Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e10:25AM – 10:35AM\u003cbr\u003eFasika Woreta, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eArtificial Intelligence in Cataract Management\u003c\/strong\u003e\u003cbr\u003e10:35AM – 10:45AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLate Complications after Uncomplicated Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e10:45AM – 10:55AM\u003cbr\u003eRobert S Weinberg, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHydrogel-assisted Corneal Regeneration: Rabbit Models\u003c\/strong\u003e\u003cbr\u003e10:55AM – 11:05AM\u003cbr\u003eSamuel Yiu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e11:05AM – 11:15AM\u003cbr\u003eYassine Daoud, MD\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eInteresting Cases\u003c\/strong\u003e\u003cbr\u003e11:15AM – 11:30AM\u003cbr\u003eYassine Daoud, MD\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManagement of Complete Tear Duct Loss\u003c\/strong\u003e\u003cbr\u003e11:30AM – 11:40AM\u003cbr\u003eNicholas mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Oculoplastic Surgery\u003c\/strong\u003e\u003cbr\u003e11:30AM – 1:30PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManagement of Ptosis in 2022\u003c\/strong\u003e\u003cbr\u003e11:40AM – 11:50AM\u003cbr\u003eFatemeh Rajaii, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTrends in the Diagnosis of Giant Cell Arteritis\u003c\/strong\u003e\u003cbr\u003e11:50AM – 12:00PM\u003cbr\u003eColin Bacorn, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePediatric Eyelid Ptosis\u003c\/strong\u003e\u003cbr\u003e12:00PM – 12:10PM\u003cbr\u003eEmily Li, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTargeted Therapies for Periocular Neoplasms\u003c\/strong\u003e\u003cbr\u003e12:10PM – 12:20PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e12:20PM – 12:30PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Uveitis\u003c\/strong\u003e\u003cbr\u003e1:30PM – 3:00PM\u003cbr\u003eBryn Burkholder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eViral Anterior Uveitis\u003c\/strong\u003e\u003cbr\u003e1:30PM – 1:45PM\u003cbr\u003eBenjamin C Chaon, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery in Uveitis\u003c\/strong\u003e\u003cbr\u003e1:45PM – 2:00PM\u003cbr\u003eBryn Burkholder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOcular Complications of Immunotherapy\u003c\/strong\u003e\u003cbr\u003e2:00PM – 2:15PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e2:15PM – 2:30PM\u003cbr\u003eMeghan Berkenstock, MD\u003cbr\u003eBryn Burkholder, MD\u003cbr\u003eBenjamin C Chaon, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGraves Ophthalmopathy in the Monoclonal Antibody Era\u003c\/strong\u003e\u003cbr\u003e3:00PM – 3:15PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Neuro-Ophthalmology\u003c\/strong\u003e\u003cbr\u003e3:00PM – 4:00PM\u003cbr\u003eAmanda Henderson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSkull Base Cerebrospinal Leak in Pseudotumor Cerebri\u003c\/strong\u003e\u003cbr\u003e3:15PM – 3:30PM\u003cbr\u003eMichael Carper, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNon-Arteritic Anterior Ischemic Optic Neuropathy\u003c\/strong\u003e\u003cbr\u003e3:30PM – 3:45PM\u003cbr\u003eColin P Kane, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTransient Monocular Vision Loss\u003c\/strong\u003e\u003cbr\u003e3:45PM – 4:00PM\u003cbr\u003eAmanda Henderson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Optometric Session\u003c\/strong\u003e\u003cbr\u003e4:00PM – 5:00PM\u003cbr\u003eJack Prince, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Socioeconomic Session\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:30PM\u003cbr\u003eDavid Glasser, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Socioeconomic Session\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:30PM\u003cbr\u003eRenee Bovelle, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThyroid Eye Disease: A Review and Update\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:10PM\u003cbr\u003eJack Prince, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome and Session Goals\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:05PM\u003cbr\u003eRenee Bovelle, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: Making it in Private Practice\u003c\/strong\u003e\u003cbr\u003e4:05PM – 4:45PM\u003cbr\u003eBasil S Morgan, MD\u003cbr\u003eDavid Baranano, MD, PhD\u003cbr\u003eRenee Bovelle, MD\u003cbr\u003eDaniel Briceland, MD\u003cbr\u003eLawson Grumbine, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Evaporative Dry Eye Related to Menopause\u003c\/strong\u003e\u003cbr\u003e4:10PM – 4:20PM\u003cbr\u003eLauren Gormley, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOcular Pharmaceuticals Update\u003c\/strong\u003e\u003cbr\u003e4:20PM – 4:30PM\u003cbr\u003eBryce St.Clair, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eExposure Keratopathy and Scleral Lenses\u003c\/strong\u003e\u003cbr\u003e4:30PM – 4:40PM\u003cbr\u003eAnisa Gire, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOphthalmology after COVID-19: AAO Considerations for Ophthalmologists and Trainees\u003c\/strong\u003e\u003cbr\u003e4:30PM – 5:00PM\u003cbr\u003eDaniel Briceland, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHysterical Amblyopia\u003c\/strong\u003e\u003cbr\u003e4:40PM – 4:50PM\u003cbr\u003eKatharine A Funari, OD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e4:45PM – 5:00PM\u003cbr\u003eJella A An, MD, MBA\u003cbr\u003eDavid Glasser, MD\u003cbr\u003eRenee Bovelle, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCoding Updates for 2023\u003c\/strong\u003e\u003cbr\u003e5:00PM – 5:10PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCarrier Challenges: Step Therapy; Hoops and Hurdles\u003c\/strong\u003e\u003cbr\u003e5:10PM – 5:20PM\u003cbr\u003eDavid Glasser, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMaryland Legislative Update\u003c\/strong\u003e\u003cbr\u003e5:20PM – 5:30PM\u003cbr\u003eLawson Grumbine, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWashington Update\u003c\/strong\u003e\u003cbr\u003e5:30PM – 5:40PM\u003cbr\u003eBrandy Keys, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e5:40PM – 5:55PM\u003cbr\u003eDavid Glasser, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClosing Remarks\u003c\/strong\u003e\u003cbr\u003e5:55PM – 6:00PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eFriday, December 2, 2022\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIntroduction to Day 2 Current Concepts in Ophthalmology\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Retina – Part I\u003c\/strong\u003e\u003cbr\u003e8:00AM – 10:20AM\u003cbr\u003eAmir H Kashani, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Retina – Part I\u003c\/strong\u003e\u003cbr\u003e8:00AM – 10:20AM\u003cbr\u003eJ. Fernando Arevalo, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBalancing Safety and Convenience of Port Delivery Systems for Anti-VEGF Treatments\u003c\/strong\u003e\u003cbr\u003e8:10AM – 8:20AM\u003cbr\u003eJ. Fernando Arevalo, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAl Applications to Retina\u003c\/strong\u003e\u003cbr\u003e8:20AM – 8:30AM\u003cbr\u003eT. Y. Alvin Liu, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLapses in Care during Management of Proliferative Diabetic Retinopathy\u003c\/strong\u003e\u003cbr\u003e8:30AM – 8:40AM\u003cbr\u003eSusan Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUltra-Wide Field Imaging in Diabetic Retinopathy\u003c\/strong\u003e\u003cbr\u003e8:40AM – 8:50AM\u003cbr\u003eMira Sachdeva, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answer \/ Discussion\u003c\/strong\u003e\u003cbr\u003e8:50AM – 9:00AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAqueous Biomarkers Potentially Predicting Response to Anti-VEGF Therapy: Towards Precision Medicine for Neovascular AMD\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:10AM\u003cbr\u003eAkrit Sodhi, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTranslational and Clinical Research for Geographic Atrophy\u003c\/strong\u003e\u003cbr\u003e9:10AM – 9:20AM\u003cbr\u003eJames Handa, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Anti-VEGF Treatment Regimens: Fixed, PRN, Treat and Extend, Step Therapies\u003c\/strong\u003e\u003cbr\u003e9:20AM – 9:30AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePotential Clinical Relevance of New Treatments for Geographic Atrophy\u003c\/strong\u003e\u003cbr\u003e9:30AM – 9:40AM\u003cbr\u003eNarine Viruni, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e9:40AM – 9:50AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDEI in Retina and Ophthalmology in 2022\u003c\/strong\u003e\u003cbr\u003e10:20AM – 10:30AM\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Retina – Part II\u003c\/strong\u003e\u003cbr\u003e10:20AM – 11:30AM\u003cbr\u003eCindy X Cai, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Retina – Part II\u003c\/strong\u003e\u003cbr\u003e10:20AM – 11:30AM\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Applications of OCT Angiography\u003c\/strong\u003e\u003cbr\u003e10:30AM – 10:40AM\u003cbr\u003eAmir H Kashani, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDME: Prophylaxis vs Treat when VA Loss\u003c\/strong\u003e\u003cbr\u003e10:40AM – 10:50AM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e10:50AM – 11:00AM\u003cbr\u003eCindy X Cai, MD\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBig Data – Big Promises in Ophthalmology\u003c\/strong\u003e\u003cbr\u003e11:00AM – 11:10AM\u003cbr\u003eCindy X Cai, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOcular Side Effects of Systemic Chemotherapy\u003c\/strong\u003e\u003cbr\u003e11:10AM – 11:20AM\u003cbr\u003eKapil Mishra, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e11:20AM – 11:30AM\u003cbr\u003eCindy X Cai, MD\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNew directions in Ophthalmology, Novel Insights\u003c\/strong\u003e\u003cbr\u003e11:30AM – 12:00PM\u003cbr\u003eCecilia Lee, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Pediatric Ophthalmology\u003c\/strong\u003e\u003cbr\u003e1:00PM – 3:00PM\u003cbr\u003eMegan E Collins, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Pediatric Ophthalmology\u003c\/strong\u003e\u003cbr\u003e1:00PM – 3:00PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSlab-Off Prism for Symptomatic, Incomitant Vertical Strabismus\u003c\/strong\u003e\u003cbr\u003e1:00PM – 1:09PM\u003cbr\u003eAlexander Christoff, CO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetinoscopy for the Cataract Surgeon\u003c\/strong\u003e\u003cbr\u003e1:10PM – 1:18PM\u003cbr\u003eEdward Kuwera, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWilmer’s Genetic Eye Disease Center\u003c\/strong\u003e\u003cbr\u003e1:19PM – 1:27PM\u003cbr\u003eJefferson Doyle, MD, PhD, MHS, MA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAddressing Health Disparities in Pediatric Eye Care\u003c\/strong\u003e\u003cbr\u003e1:28PM – 1:37PM\u003cbr\u003eMegan E Collins, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe Pediatric Glaucoma Suspect\u003c\/strong\u003e\u003cbr\u003e1:38PM – 1:47PM\u003cbr\u003eCourtney Kraus, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRe-establishing Strabismus Surgical Outreach in the Developing World Post COVID\u003c\/strong\u003e\u003cbr\u003e1:48PM – 2:07PM\u003cbr\u003eCody Richardson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eProgressive Power Glasses: Double (Vision) Trouble\u003c\/strong\u003e\u003cbr\u003e2:08PM – 2:17PM\u003cbr\u003eDavid L Guyton, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMyopia Control Strategies – Status for 2023\u003c\/strong\u003e\u003cbr\u003e2:18PM – 2:27PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestion and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e2:27PM – 2:35PM\u003cbr\u003eAlexander Christoff, CO\u003cbr\u003eMegan E Collins, MD, MPH\u003cbr\u003eJefferson Doyle, MD, PhD, MHS, MA\u003cbr\u003eDavid L Guyton, MD\u003cbr\u003eCourtney Kraus, MD\u003cbr\u003eEdward Kuwera, MD\u003cbr\u003eMichael Repka, MD, MBA\u003cbr\u003eCody Richardson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma MIGS Plumbing: Unclogging the Drain and Turning Down the Faucet\u003c\/strong\u003e\u003cbr\u003e3:00PM – 3:15PM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModerator: Glaucoma\u003c\/strong\u003e\u003cbr\u003e3:00PM – 4:30PM\u003cbr\u003eHenry Jampel, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWhen MIGS Fail—What are Some Minimally Invasive Options\u003c\/strong\u003e\u003cbr\u003e3:15PM – 3:30PM\u003cbr\u003eJella A An, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Challenges 2022\u003c\/strong\u003e\u003cbr\u003e3:30PM – 4:30PM\u003cbr\u003eJella A An, MD, MBA\u003cbr\u003eHenry Jampel, MD\u003cbr\u003eThomas V Johnson III, MD, PhD\u003cbr\u003eElyse J McGlumphy, MD\u003cbr\u003eIan Pitha, MD, PhD\u003cbr\u003eHarry A Quigley, MD\u003cbr\u003ePradeep Ramulu, MD, PhD\u003cbr\u003eJithin Yohannan, MD, MPH\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954505027682,"sku":"MED-AMB04862","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Johns-Hopkins-Wilmer-Eye-Institutes-35th-Annual-Current-Concepts-in-Ophthalmology-2022-768x510-1.jpg?v=1779378353","url":"https:\/\/meducourse.com\/products\/johns-hopkins-wilmer-eye-institutes-35th-annual-current-concepts-in-ophthalmology-2022","provider":"Meducourse","version":"1.0","type":"link"}